Inventor · disambiguated record
Reshma Abdulla Rangwala
Also filed as: RANGWALA RESHMA · RANGWALA RESHMA A · RANGWALA RESHMA ABDULLA
3 granted patents·11 pending applications·0 citations·filing 2018–2024
39Inventor score
Top patents by PatentIndex Score
14 records- 0169US2025066507A1Methods of treating cancer with a combination of an anti-pd-1 antibody and an anti-tissue factor antibody-drug conjugateGENMAB AS·Filed 2024·Application pending·0 cites
- 0266US2024252673A1Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancerGENMAB AS·Filed 2023·Application pending·0 cites
- 0356US12246025B2Methods of treating cancer with a combination of a platinum-based agent and an anti-tissue factor antibody-drug conjugateGENMAB AS·Filed 2019·Granted Mar 11, 2025·0 cites·25 claims
- 0454US2021107980A1Methods of treating cancer with a combination of an anti-pd-1 antibody and an anti-tissue factor antibody-drug conjugateGENMAB AS·Filed 2019·Application pending·0 cites
- 0550US2023257479A1Bispecific antibodies binding to 5t4 and cd3 for use in treatment of cancerGENMAB AS·Filed 2020·Application pending·0 cites
- 0648US12453781B2Methods of treating cancer with a combination of an anti-VEGF antibody and an anti-tissue factor antibody-drug conjugateGENMAB AS·Filed 2019·Granted Oct 28, 2025·0 cites·36 claims
- 0748US2021308208A1Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancerGENMAB AS·Filed 2019·Application pending·0 cites
- 0848US2021177987A1Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancerGENMAB AS·Filed 2018·Application pending·0 cites
- 0946US2022387485A1Methods of treating cancer with a combination of a platinum-based agent and an anti-tissue factor antibody-drug conjugateGENMAB AS·Filed 2020·Application pending·0 cites
- 1045US2021030888A1Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancerGENMAB AS·Filed 2019·Application pending·0 cites
- 1144US2023027495A1Methods of treating cancer with a combination of an anti-pd-1 antibody and an anti-tissue factor antibody-drug conjugateGENMAB AS·Filed 2020·Application pending·0 cites
- 1244US2023263902A1Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancerGENMAB AS·Filed 2021·Application pending·0 cites
- 1342US2024374685A1Methods of treating locally advanced or metastatic pancreatic adenocarcinoma using axl decoy receptors as first-line therapyARAVIVE INC·Filed 2022·Application pending·0 cites
- 1438US12324841B2Methods of treating cancer with a combination of an anti-PD-1 antibody and an anti-tissue factor antibody-drug conjugateGENMAB AS·Filed 2019·Granted Jun 10, 2025·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Reshma Abdulla Rangwala files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →